{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:32:04Z","timestamp":1788503524153,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"am","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007699","name":"University of Georgia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N93019C00052\u2033"],"award-info":[{"award-number":["75N93019C00052\u2033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008065","name":"Georgia Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.vaccine.2023.12.084","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T16:03:07Z","timestamp":1706630587000},"page":"1184-1192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Flu-COVID combo recombinant protein vaccines elicited protective immune responses against both influenza and SARS-CoV-2 viruses infection"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6889-5301","authenticated-orcid":false,"given":"Ying","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3792-690X","authenticated-orcid":false,"given":"Hua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Forgacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.12.084_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","volume":"4","author":"Krammer","year":"2018","journal-title":"Influenza Nat Rev Dis Primers"},{"key":"10.1016\/j.vaccine.2023.12.084_b0010","unstructured":"WHO. WHO Coronavirus (COVID-19) Dashboard. 2023."},{"key":"10.1016\/j.vaccine.2023.12.084_b0015","article-title":"COVID-19 and Influenza Co-infection: A Systematic Review and Meta-Analysis","volume":"8","author":"Dadashi","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.vaccine.2023.12.084_b0020","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/ije\/dyab081","article-title":"Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design","volume":"50","author":"Stowe","year":"2021","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2023.12.084_b0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.virol.2022.09.009","article-title":"SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021\u20132022 influenza season","volume":"576","author":"Tang","year":"2022","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2023.12.084_b0030","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1001\/jama.2020.6266","article-title":"Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2023.12.084_b0035","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.15585\/mmwr.mm7150a4","article-title":"Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza - United States, 2021\u201322 Influenza Season","volume":"71","author":"Adams","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2023.12.084_b0040","unstructured":"Mix-Ups Between the Influenza (Flu) Vaccine and COVID-19 Vaccines. Institute for Safe Medication Practices. 2021, October 7."},{"key":"10.1016\/j.vaccine.2023.12.084_b0045","unstructured":"Pfizer. Pfizer and BioNTech Initiate Phase 1 Study of Single Dose mRNA-Based Combination Vaccine Candidate for Influenza and COVID-19. 2022."},{"key":"10.1016\/j.vaccine.2023.12.084_b0050","unstructured":"Novavax. Novavax COVID-19-Influenza Combination Vaccine Candidate Induced Antibody and T-Cell Responses Against SARS-CoV-2 and Homologous and Heterologous Influenza Strains. 2022."},{"key":"10.1016\/j.vaccine.2023.12.084_b0055","first-page":"9","article-title":"Next Generation of Computationally Optimized Broadly Reactive HA Vaccines Elicited Cross-Reactive Immune Responses and Provided Protection against H1N1 Virus Infection","author":"Huang","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2023.12.084_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.707339","article-title":"Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 Viruses","volume":"12","author":"Allen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.12.084_b0065","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01283-17","article-title":"Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses","volume":"91","author":"Carter","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.12.084_b0070","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01581-17","article-title":"Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants","volume":"91","author":"Wong","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.12.084_b0075","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01526-20","article-title":"Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges","volume":"95","author":"Reneer","year":"2020","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.12.084_b0080","first-page":"10","article-title":"Next-Generation Computationally Designed Influenza Hemagglutinin Vaccines Protect against H5Nx Virus Infections","author":"Nunez","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.vaccine.2023.12.084_b0085","first-page":"8","article-title":"High-Yield Expression and Purification of Recombinant Influenza Virus Proteins from Stably-Transfected Mammalian Cell Lines","author":"Ecker","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2023.12.084_b0090","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1128\/JVI.03152-15","article-title":"Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses","volume":"90","author":"Carter","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.12.084_b0095","series-title":"Guideline on Influenza Vaccines: Non-Clinical and Clinical Module (Draft)","author":"Agency","year":"2014"},{"key":"10.1016\/j.vaccine.2023.12.084_b0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1743-422X-3-63","article-title":"New low-viscosity overlay medium for viral plaque assays","volume":"3","author":"Matrosovich","year":"2006","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2023.12.084_b0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jviromet.2011.10.003","article-title":"High throughput virus plaque quantitation using a flatbed scanner","volume":"179","author":"Sullivan","year":"2012","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2023.12.084_b0110","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/jcm.23.2.240-245.1986","article-title":"Characterization and evaluation of monoclonal antibodies developed for typing influenza A and influenza B viruses","volume":"23","author":"Walls","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2023.12.084_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.728021","article-title":"SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naive and Pre-Immune Humans","volume":"12","author":"Forgacs","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.12.084_b0120","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.4049\/jimmunol.1701174","article-title":"Infection of Ferrets with Influenza Virus Elicits a Light Chain-Biased Antibody Response against Hemagglutinin","volume":"199","author":"Kirchenbaum","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2023.12.084_b0125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/d41586-023-00014-3","article-title":"Coronavirus variant XBB.1.5 rises in the United States - is it a global threat?","volume":"613","author":"Callaway","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2023.12.084_b0130","first-page":"e939580","article-title":"The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread","volume":"29","author":"Editorial","year":"2023","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.vaccine.2023.12.084_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104297","article-title":"A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion core","volume":"85","author":"Shi","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2023.12.084_b0140","doi-asserted-by":"crossref","first-page":"e0157821","DOI":"10.1128\/jvi.01578-21","article-title":"A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice","volume":"96","author":"Cao","year":"2022","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.12.084_b0145","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41422-020-0387-5","article-title":"A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2","volume":"30","author":"Tai","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.vaccine.2023.12.084_b0150","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa2202261","article-title":"Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults","volume":"386","author":"Dai","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.12.084_b0155","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118312119","article-title":"Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants","volume":"119","author":"Kingstad-Bakke","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2023.12.084_b0160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-021-01122-w","article-title":"The T cell immune response against SARS-CoV-2","volume":"23","author":"Moss","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2023.12.084_b0165","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.12.084_b0170","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.abm0271","article-title":"A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes","volume":"378","author":"Arevalo","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2023.12.084_b0175","doi-asserted-by":"crossref","first-page":"E5944","DOI":"10.1073\/pnas.1613225113","article-title":"Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact","volume":"113","author":"Leon","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2023.12.084_b0180","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1016\/j.vaccine.2021.08.092","article-title":"Association of Flu specific and SARS-CoV-2 specific CD4 T cell responses in SARS-CoV-2 infected asymptomatic heath care workers","volume":"39","author":"Pallikkuth","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.12.084_b0185","article-title":"Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil. BMJ","author":"Fink","year":"2020","journal-title":"Evid Based Med"},{"key":"10.1016\/j.vaccine.2023.12.084_b0190","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s11739-021-02702-2","article-title":"Effect of influenza vaccine on COVID-19 mortality: a retrospective study","volume":"16","author":"Candelli","year":"2021","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.vaccine.2023.12.084_b0195","first-page":"7","article-title":"Cross-reactivity of SARS-CoV-2- and influenza A-specific T cells in individuals exposed to SARS-CoV-2. JCI","author":"Chaisawangwong","year":"2022","journal-title":"Insight"},{"key":"10.1016\/j.vaccine.2023.12.084_b0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0377-1237(07)80067-0","article-title":"Combination Vaccines","volume":"63","author":"Jatana","year":"2007","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.vaccine.2023.12.084_b0205","doi-asserted-by":"crossref","first-page":"e0165221","DOI":"10.1128\/jvi.01652-21","article-title":"Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019","volume":"96","author":"Allen","year":"2022","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.12.084_b0210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.lfs.2018.05.056","article-title":"Mouse strain and sex as determinants of immune response to trivalent influenza vaccine","volume":"207","author":"Petrovic","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.vaccine.2023.12.084_b0215","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1101\/gr.9.9.878","article-title":"Panel of microsatellite markers for whole-genome scans and radiation hybrid mapping and a mouse family tree","volume":"9","author":"Schalkwyk","year":"1999","journal-title":"Genome Res"},{"key":"10.1016\/j.vaccine.2023.12.084_b0220","doi-asserted-by":"crossref","first-page":"11931","DOI":"10.1073\/pnas.1609316113","article-title":"Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus","volume":"113","author":"He","year":"2016","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23015438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23015438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:35:29Z","timestamp":1759404929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23015438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0264410X23015438"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.12.084","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flu-COVID combo recombinant protein vaccines elicited protective immune responses against both influenza and SARS-CoV-2 viruses infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.12.084","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}